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Introduction: Hepatitis C virus has been under-recognized as an etiologic factor for polyarteritis nodosa and the
presence of hepatitis C antigenemia in patients with polyarteritis nodosa has been reported as insignificant. In the
literature hepatitis C virus-associated polyarteritis nodosa is a rare and controversial entity.
Case presentation: A 34-year-old Sri Lankan Tamil man presented to our facility with a two-week history of
slow-resolving pneumonia of the right mid and lower zones. On physical examination he had panniculitic type
tender skin nodules with background livedo reticularis. A skin biopsy was suggestive of a small and medium vessel
vasculitis compatible with polyarteritis nodosa. He was tested positive for hepatitis C antibodies. A serum
cryoglobulin test was negative but perinuclear antineutrophilic cytoplasmic antibody test was positive. Serum
complement levels were reduced. He was diagnosed as having classic polyarteritis nodosa associated with hepatitis
C infection. He later developed left-sided radiculopathy involving both upper and lower limbs and an ischemic
cardiac event. His hepatitis C infection was managed with polyethylene glycol-interferon 2α combined with oral
ribavirin. Simultaneously, his classic polyarteritis nodosa was treated with prednisolone and cyclophosphamide. He
made a good recovery.
Conclusions: Hepatitis C virus infection is capable of inducing a fulminant form of vasculitis in the form of
polyarteritis nodosa. It may be easily confused early in its course with mixed cryoglobulinemia, which is commonly
known to be associated with hepatitis C virus. Awareness of hepatitis C virus-related polyarteritis nodosa helps in
diagnosing the condition early so combined immunosuppressive and antiviral treatment can be started as soon as
possible.
Keywords: Hepatitis C virus, Vasculitis, Polyarteritis nodosaIntroduction
Hepatitis B virus (HBV) is a well-known etiologic factor
of polyarteritis nodosa (PAN), whereas hepatitis C virus
(HCV) is commonly associated with cryoglobulinemic
vasculitis [1,2]. HCV has been under-recognized as an
etiologic factor for PAN and the presence of hepatitis C
antigenemia in patients with PAN has been reported as
being insignificant [3,4]. In the literature HCV-
associated PAN is a rare and controversial entity. Here,
we report a case of PAN related to HCV infection.
Case presentation
A 34-year-old, unmarried, previously healthy Sri Lankan
Tamil man was transferred from a private hospital with* Correspondence: damith_rodrigo@yahoo.com
University Medical Unit, Colombo North Teaching Hospital, Ragama, Sri
Lanka
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reproduction in any medium, provided the ora two-week history of slow-resolving pneumonia of the
right mid and lower zones. He had recently returned to
Sri Lanka after working abroad. He complained of mal-
aise, loss of appetite and significant loss of weight. On
physical examination he was found to have generalized
tender lymphadenopathy, and panniculitic type tender,
hard skin nodules were scattered all over his body with
background livedo reticularis and a few ulcers (Figure 1).
A respiratory system examination showed right mid and
lower zone bronchial breathing.
A chest X-ray showed a resolving right-sided mid and
lower zone consolidation. His hemoglobin level was
10.6g/dL with a total leukocyte count of 4.89×109 cells/L
and platelet count of 172×109 cells/L. Renal function test
results were within normal limits. His liver profile
showed an aspartate aminotransferase level of 71U/L,
alanine aminotransferase level of 23U/L and seruml Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Panniculitic type skin rash with tender hard nodules.
Figure 2 Skin biopsy showing perivascular lymphocytic and
neutrophilic infiltration with fibrinoid necrosis of vessel wall
with leukocytoclasia and red cell extravasations.
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tion rate (ESR) was 88mm in the first hour and
C-reactive protein level was 32.8mg/dL (normal
<0.8mg/dL). Ultrasound of our patient’s abdomen showed
hepatosplenomegaly.
Hepatitis serology was performed and he was found to
be positive for hepatitis C antibodies (anti-HCV). Initial
HCV polymerase chain reaction tests showed 6000 viral
copies/mL. He was tested negative for hepatitis B surface
antigen and anti-HIV. Tests for rheumatoid factor and
serum cryoglobulin were negative, but a test for peri-
nuclear antineutrophilic cytoplasmic antibody (pANCA)
was positive. His serum complement levels were reduced
with C3=56mg/dL (normal 83 to 111) and C4=3mg/dL
(normal 12 to 36).
While in the ward our patient developed a lower
motor neuron type, left-sided, painful weakness in both
upper and lower limbs. Nerve conduction tests con-
firmed a left-sided radiculopathy. He underwent skin bi-
opsy for the panniculitis, and histology results showed a
perivascular lymphocytic and neutrophilic infiltration
with fibrinoid necrosis of the vessel wall with leukocyto-
clasia and red cell extravasations. The features were
suggestive of a small and medium vessel vasculitis com-
patible with polyarteritis nodosa (Figure 2).
Our patient was discharged with a plan to readmit in
one week to start antiviral treatment for hepatitis C.During his second admission he complained of a left-
sided ischemic type chest pain with autonomic symp-
toms, and was found to have high blood pressure of
210/160mmHg. His electrocardiogram showed acute an-
terolateral ischemia. A troponin I test was negative, but
a two-dimensional echocardiogram showed global hypo-
kinesia with dilated cardiomyopathy. Considering his
young age and in the absence of coronary artery disease
risk factors except for smoking, the possibility that the
acute coronary event was related to the vasculitis
process was considered.
Our patient was diagnosed as having classic polyarteri-
tis nodosa (cPAN) associated with hepatitis C infection.
He fulfilled the American College of Rheumatology
(ACR) criteria and the Chapel Hill Consensus Confer-
ence (CHCC) nomenclature of systemic vasculitis for
the diagnosis of classic polyarteritis nodosa with cardiac,
neurological and cutaneous involvement [5,6].
After being treated for the acute coronary event he was
started on treatment for the underlying conditions. His
hepatitis C infection was treated with polyethylene glycol-
interferon 2α 180μg weekly combined with oral ribavirin
400mg three times a day. Simultaneously, he was started
on prednisolone 10mg twice a day and oral cyclophospha-
mide 25mg once a day for classic polyarteritis nodosa.
He was reviewed after six weeks and was found to
have made a good recovery with healed skin lesions and
improvement of motor weakness. His blood pressure
was 110/70mmHg and his ESR was normal at 12mm in
the first hour. We have now been following him up in
our clinic for nearly six months without any relapse.
Discussion
HBV was once the cause of up to 30% of PAN cases [7].
Widespread use of the hepatitis B vaccine has
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which is now estimated to account for less than 8% of
all PAN cases [8]. Mixed cryoglobulinemia was previ-
ously the most widely known extrahepatic vasculitis
manifestation of hepatitis C virus. In a recent study
among a cohort of 161 patients with HCV-related vascu-
litis, 31 (19.3%) were diagnosed as having PAN, and
compared with HCV-mixed cryoglobulinemia (MC) vas-
culitis, HCV-PAN displayed a more severe and acute
clinical presentation and higher rate of clinical remission
[9]. Similar results were shown in another study by
Cacoub et al. [10]. Corticosteroids are the cornerstone
of treatment for PAN, and are combined with cyclophos-
phamide to control its severe life-threatening complica-
tions. There is also a recent report of a life-threatening
hepatitis C virus-associated polyarteritis nodosa success-
fully treated with rituximab [11].
Conclusions
In summary, we would like to highlight the possibility of
HCV infection being capable of inducing a fulminant
type of vasculitis in the form of PAN. It may be easily
confused early in its course with mixed cryoglobuline-
mia, which is commonly known to be associated with
hepatitis C virus. Awareness of HCV-related PAN helps
in diagnosing the condition early and ensuring combined
immunosuppressive and antiviral treatment is started as
soon as possible.
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